[Non-Invasive Brain Stimulation in Psychiatric Disorders]
Fortschritte Der Neurologie-Psychiatrie
|January 26, 2022
Summary
Non-invasive brain stimulation, like transcranial magnetic stimulation (TMS), offers a new treatment for mental disorders. While approved in the US for depression, its use is limited in Europe.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Technology
Background:
- Non-invasive brain stimulation (NIBS) leverages neurophysiological findings for integrated mental disorder treatment.
- Established methods like transcranial magnetic stimulation (TMS) are recognized treatments for specific psychiatric conditions.
Purpose of the Study:
- To describe available NIBS technologies and their biological mechanisms.
- To outline clinical indications and applications of TMS.
- To summarize the clinical evidence for TMS based on recent guidelines.
Main Methods:
- Review of available non-invasive brain stimulation technologies.
- Analysis of biological mechanisms of action.
- Summary of clinical evidence and guidelines for TMS.
Main Results:
- Transcranial magnetic stimulation (TMS) received FDA approval for refractory depression in 2008.
- TMS is not widely adopted in Europe, including Germany, even in academic settings.
- The article details TMS technology, mechanisms, indications, and evidence.
Conclusions:
- NIBS, particularly TMS, presents a viable therapeutic option for mental health disorders.
- Wider adoption of TMS in Europe requires further dissemination of clinical evidence and guidelines.
